Cite
HARVARD Citation
Seligson, N. et al. (2021). Developing Drugs for Tissue‐Agnostic Indications: A Paradigm Shift in Leveraging Cancer Biology for Precision Medicine. Clinical pharmacology & therapeutics. 109 (2), pp. 334-342. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Seligson, N. et al. (2021). Developing Drugs for Tissue‐Agnostic Indications: A Paradigm Shift in Leveraging Cancer Biology for Precision Medicine. Clinical pharmacology & therapeutics. 109 (2), pp. 334-342. [Online].